CRYPTOBIOTIX Trademark

Trademark Overview

On Thursday, September 23, 2021, a trademark application was filed for CRYPTOBIOTIX with the United States Patent and Trademark Office. The USPTO has given the CRYPTOBIOTIX trademark a serial number of 79327930. The federal status of this trademark filing is REGISTERED as of Tuesday, October 31, 2023. This trademark is owned by Cryptobiotix. The CRYPTOBIOTIX trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting preclinical and clinical studies, trials and tests, namely, conducting preclinical and clinical trials for food components and pharmaceutical products
cryptobiotix

General Information

Serial Number79327930
Word MarkCRYPTOBIOTIX
Filing DateThursday, September 23, 2021
Status700 - REGISTERED
Status DateTuesday, October 31, 2023
Registration Number7203773
Registration DateTuesday, October 31, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 15, 2023

Trademark Statements

Goods and ServicesConducting preclinical and clinical studies, trials and tests, namely, conducting preclinical and clinical trials for food components and pharmaceutical products

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, December 13, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCryptobiotix
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressBE
Party NameCryptobiotix
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressBE
Party NameCryptobiotix
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBE

Trademark Events

Event DateEvent Description
Monday, February 26, 2024FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, February 2, 2024FINAL DISPOSITION NOTICE SENT TO IB
Friday, February 2, 2024FINAL DISPOSITION PROCESSED
Wednesday, January 31, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, October 31, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 31, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, August 15, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2023PUBLISHED FOR OPPOSITION
Monday, August 14, 2023NOTIFICATION PROCESSED BY IB
Wednesday, July 26, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, July 26, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, July 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, May 29, 2023NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Wednesday, May 10, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, May 10, 2023NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Friday, May 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, February 21, 2023REFUSAL PROCESSED BY IB
Wednesday, January 25, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, January 25, 2023NON-FINAL ACTION E-MAILED
Wednesday, January 25, 2023NON-FINAL ACTION WRITTEN
Wednesday, December 14, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, December 14, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, December 14, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, August 17, 2022REFUSAL PROCESSED BY IB
Friday, July 22, 2022NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Friday, July 22, 2022REFUSAL PROCESSED BY MPU
Tuesday, June 28, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, June 27, 2022NON-FINAL ACTION WRITTEN
Saturday, June 25, 2022ASSIGNED TO EXAMINER
Friday, December 17, 2021APPLICATION FILING RECEIPT MAILED
Monday, December 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, December 9, 2021SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

cryptobiotix trials conducting clinical preclinical pharmaceutical products components tests studies namely